Analyst price target range
Corbus Pharmaceuticals Holdings Price Target: $34.03 Average
Direct answer
Corbus Pharmaceuticals Holdings's average price target is $34.03.
The verified analyst range runs from $17.25 to $48.00.
The low target implies +112.4%, the high target implies +491.1%, and the range spans 378.7% of the current price.
Forecast evidence checked September 12, 2026.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.12
- Average price target
- $34.03
- High price target
- $48.00
- Low price target
- $17.25
- Low target gap
- +112.4%
- Target upside
- +319%
- High target gap
- +491.1%
- Target range width
- 378.7%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- September 12, 2026
- Valid through
- September 19, 2026
Explore related company data
Read the frequently asked questions.
What is Corbus Pharmaceuticals Holdings's average price target?
Corbus Pharmaceuticals Holdings's verified average price target is $34.03. The target range is $17.25 to $48.00.
How far are Corbus Pharmaceuticals Holdings's low and high targets from the recorded price?
The low target implies +112.4%, while the high target implies +491.1%.
How many analysts are included in Corbus Pharmaceuticals Holdings's consensus?
The verified consensus includes 10 analysts.
How is Corbus Pharmaceuticals Holdings's target upside or downside calculated?
The average target of $34.03 is divided by the recorded price of $8.12, then one is subtracted to produce +319%. This does not guarantee a future return.
When was Corbus Pharmaceuticals Holdings's analyst forecast verified?
The data was verified on 2026-09-12. The dataset is valid through 2026-09-19.